NORMAN — A $10.8 million grant from the National Institutes of Health will enable researchers at Harold Hamm Diabetes Center at the University of Oklahoma to examine the causes and complications of diabetes to lead to new methods of treatment and, in some cases, prevent complications of the disease.
“We can no longer ignore the impact of diabetes on our state and on the world,” OU President David L. Boren said. “It is estimated that diabetes costs Oklahoma alone more than $3 billion each year, and the Centers for Disease Control predicts that one in three children born in the year 2000 will develop diabetes during their lifetime. This grant will help our researchers at Harold Hamm Diabetes Center to continue to lead the fight against these alarming statistics.”
The NIH Center of Biomedical Research Excellence, or COBRE, provides promising young researchers with the resources to build a strong foundation for research aimed at treating and preventing diabetes. The grant pairs these junior researchers with senior researchers as mentors to the development of their work, allowing new ideas and perspectives to be guided by mentors’ knowledge and expertise.
The grant also provides for the continued development of core research laboratory facilities and resources that enhance the center’s ability to perform world-class diabetes research.
“I believe that many of the major breakthroughs that will lead to a cure for diabetes will come from the contributions of young, bright scientists in the field,” said Harold Hamm, chairman and CEO of Continental Resources Inc. and chairman of the center’s board of advisors. “By providing these additional resources, I want to encourage our young investigators to look more intensely at the development of new and novel ideas that will lead to a cure for diabetes and its complications.”
Hamm, who provided the lead naming gift for the center in 2007, has bolstered the impact the COBRE grant will have by providing a $3 million gift to further diabetes research funded by the grant.